Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is O  [Clear All Filters]
Kalff, A., Khong, T., Mithraprabhu, S., Bergin, K., Reynolds, J., Bowen, K.M., Thakurta, A., Guzman, R., Wang, M., Couto, S., et al. (2019). Oral azacitidine (CC-486) in combination with lenalidomide and dexamethasone in advanced, lenalidomide-refractory multiple myeloma (ROAR study).Leuk Lymphoma1-9.
Abdel-Kader, M.Ahmed, Abdelazeem, A.Farouk, Ahmed, N.El-Moataz, Khalil, Y.Mohamed, and Mostafa, M.Ibrahim (2019). Oral rehabilitation of a case with regional odontodysplasia using a regenerative approach-A case report and a review of literature.Spec Care Dentist.
Pereira, A.R., Trivanovic, D., and Herrmann, M. (2019). Osteoarthritis as an organ disease: from the cradle to the graveApproaches to mimic the complexity of the skeletal mesenchymal stem/stromal cell niche in vitro.Eur Cell Mater37, 88-112.
Bourebaba, L., Röcken, M., and Marycz, K. (2019). Osteochondritis dissecans (OCD) in Horses - Molecular Background of its Pathogenesis and Perspectives for Progenitor Stem Cell Therapy.Stem Cell Rev.
Rumiński, S., Kalaszczyńska, I., Długosz, A., and Lewandowska-Szumieł, M. (2019). Osteogenic differentiation of human adipose-derived stem cells in 3D conditions - comparison of spheroids and polystyrene scaffolds.Eur Cell Mater37, 382-401.
Westhauser, F., Karadjian, M., Essers, C., Senger, A.-S., Hagmann, S., Schmidmaier, G., and Moghaddam, A. (2019). Osteogenic differentiation of mesenchymal stem cells is enhanced in a 45S5-supplemented β-TCP composite scaffold: an in-vitro comparison of Vitoss and Vitoss BA.Plos One14, e0212799.
Srinaath, N., Balagangadharan, K., Pooja, V., Paarkavi, U., Trishla, A., and Selvamurugan, N. (2019). Osteogenic potential of zingerone, a phenolic compound in mouse mesenchymal stem cells.Biofactors.
Ringdén, O., Boumendil, A., Labopin, M., Canaani, J., Beelen, D., Ehninger, G., Niederwieser, D., Finke, J., Stelljes, M., Gerbitz, A., et al. (2019). OUTCOME OF ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS OVER 69 YEARS OF AGE WITH ACUTE MYELOID LEUKEMIA: ON BEHALF OF THE ACUTE LEUKEMIA WORKING PARTY OF THE EBMT.Biol Blood Marrow Transplant.
Hill-Kayser, C.E., Tochner, Z., Li, Y., Kurtz, G., Lustig, R.A., James, P., Balamuth, N., Womer, R., Mattei, P., Grupp, S., et al. (2019). Outcomes after Proton Therapy for Treatment of Pediatric High-Risk Neuroblastoma.Int J Radiat Oncol Biol Phys.
Marks, D.I., Kebriaei, P., Stelljes, M., Gökbuget, N., Kantarjian, H., Advani, A.S., Merchant, A., Stock, W., Cassaday, R.D., Wang, T., et al. (2019). Outcomes of allogeneic stem cell transplantation after inotuzumab ozogamicin treatment for relapsed or refractory acute lymphoblastic leukemia.Biol Blood Marrow Transplant.
Sanders, S., Chua, N., Larouche, J.-F., Owen, C., Shafey, M., and Stewart, D.A. (2019). Outcomes of Consecutively Diagnosed Primary Central Nervous System Lymphoma Patients Using the Alberta Lymphoma Clinical Practice Guideline Incorporating Thiotepa-Busulfan Conditioning for Transplant-Eligible Patients.Biol Blood Marrow Transplant.
Halder, R., Mishra, P., Dhawan, R., Aggarwal, M., Seth, T., Mahapatra, M., and Saxena, R. (2019). Outcomes of paroxysmal nocturnal hemoglobinuria in the pediatric age group in a resource-constrained setting.Pediatr Blood Cancere27712.
Hatina, J., Boesch, M., Sopper, S., Kripnerova, M., Wolf, D., Reimer, D., Marth, C., and Zeimet, A.G. (2019). Ovarian Cancer Stem Cell Heterogeneity.Adv Exp Med Biol1139, 201-221.
Su, Y.-K., Bamodu, O.Adebayo, Tzeng, Y.-M., Hsiao, M., Yeh, C.-T., and Lin, C.-M. (2019). Ovatodiolide inhibits the oncogenicity and cancer stem cell-like phenotype of glioblastoma cells, as well as potentiate the anticancer effect of temozolomide.Phytomedicine61, 152840.
Xiang, J., Ding, Y., Li, J., Zhao, X., Sun, Y., Wang, D., Wang, L., and Chen, Y. (2019). Ovatodiolides: Scalable Protection-free Syntheses, Configuration Determination and Biological Evaluation against Hepatic Cancer Stem Cells.Angew Chem Int Ed Engl.
Lu, C., Shi, X., Allen, A., Baez-Nieto, D., Nikish, A., Sanjana, N.E., and Pan, J.Q. (2019). Overexpression of NEUROG2 and NEUROG1 in human embryonic stem cells produces a network of excitatory and inhibitory neurons.Faseb Jfj201801110RR.
Stojanovska, V., Prakash, M., McQuade, R., Fraser, S., Apostolopoulos, V., Sakkal, S., and Nurgali, K. (2019). Oxaliplatin Treatment Alters Systemic Immune Responses.Biomed Res Int2019, 4650695.
Perikamana, S.Kumar Madh, Lee, S.Min, Lee, J., Ahmad, T., Lee, M., Yang, H.-S., and Shin, H. (2019). Oxidative Epigallocatechin Gallate Coating on Polymeric Substrates for Bone Tissue Regeneration.Macromol Bioscie1800392.
Klontzas, M.E., Reakasame, S., Silva, R., Morais, J.C.F., Vernardis, S., MacFarlane, R.J., Heliotis, M., Tsiridis, E., Panoskaltsis, N., Boccaccini, A.R., et al. (2019). Oxidized alginate hydrogels with the GHK peptide enhance cord blood mesenchymal stem cell osteogenesis: a paradigm for metabolomics-based evaluation of biomaterial design.Acta Biomater.
Papas, K.K., De Leon, H., Suszynski, T.M., and Johnson, R.C. (2019). Oxygenation strategies for encapsulated islet and beta cell transplants.Adv Drug Deliv Rev.